Loading company details...
Latest Form 4 (Sep 8, 2026): Milton Mayo Morris (Director): Sale of 6,293 shares, $37.0K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 8, 2026 | Milton Mayo Morris | Sale | 6,293 | $37.0K |
| Aug 13, 2026 | Devdatt Kurdikar, President and CEO | Purchase | 30,000 | $140.9K |
| Aug 13, 2026 | Jacob Elguicze, SVP and CFO | Purchase | 20,000 | $93.4K |
| Aug 13, 2026 | Jeffrey Z. Mann, Pres, Pharm Svc&Prod Mgmt, CLO | Purchase | 20,000 | $99.8K |
| Aug 13, 2026 | Robert J. Hombach | Purchase | 45,000 | $223.8K |
| Aug 11, 2026 | Jean Casner, Chief Human Resources Officer | Tax Withholding | 1,480 | $6.5K |
| Jun 2, 2026 | Anthony M. Roth, VP, Chief Accounting Officer | Grant/Award | 30,000 | n/a |
| Feb 13, 2026 | Robert J. Hombach | Grant/Award | 22,841 | n/a |
| Feb 13, 2026 | Milton Mayo Morris | Grant/Award | 22,841 | n/a |
| Feb 13, 2026 | Karen Prange | Grant/Award | 22,841 | n/a |